| 16:20- 16:25 |
专题报告 |
Inroduction and session Objectives
|
|
| 16:25–16:41 |
专题报告 |
New European guidelines: focus on the aortic valve
|
|
| 16:41–16:46 |
讨论 |
Discussion
|
|
| 16:46–17:02 |
专题报告 |
Transcatheter valve interventions : Innovations from China
|
|
| 17:02–17:07 |
讨论 |
Discussion
|
|
| 17:07–17:23 |
专题报告 |
Unmasking Residual Risk in Coronary Artery Disease: AI-Powered Prediction from Routine Angiography
|
|
William Wijns
|
Lambe Institute for Translational Medicine, Curam, and Saolta University Healthcare Group, National University of Ireland Galway
|
|
| 17:23–17:28 |
讨论 |
Discussion
|
|
| 17:28–17:44 |
专题报告 |
TAVI and coronary artery disease : where do we stand ? what remains to be evaluated ?
|
|
| 17:44–17:49 |
讨论 |
Discussion
|
|
| 17:49–17:50 |
专题报告 |
Concluding the CSC – PCR Joint session
|
|
William Wijns
|
Lambe Institute for Translational Medicine, Curam, and Saolta University Healthcare Group, National University of Ireland Galway
|
|
